Harlan Contract Research Services Introduces New Pathology Team

— A new team of veteran pathologists and experienced technicians has been introduced by Harlan Contract Research Services (CRS).

"Harlan CRS has focused resources on attracting and assembling the best multidisciplinary team of consultant pathologists available to augment our existing services," said Wendy Henderson, Harlan CRS global head of pathology. "With their exceptional experience, skill and efficiency, I'm confident we will exceed our clients' expectations."

In addition to assembling the new team, Henderson's responsibilities at Harlan CRS include managing harmonization between the three pathology laboratories as well as extending the pathology team's capabilities and capacities through strategic partnerships. Prior to joining Harlan CRS a year ago, Henderson had been head of pathology and principal pathologist for Aptuit in Edinburgh, Scotland, and senior veterinary pathologist for Charles River Laboratories.

At Harlan CRS pathology laboratories in Itingen, Switzerland; Barcelona, Spain; and Derbyshire, U.K., in-house teams of experienced pathologists and technicians conduct special and routine necropsy, histology and histopathology as well as fetal pathology on all laboratory animals and special species. Other services of the pathology group include special embeddings and techniques such as cryomicrotome cuts, automated immunostaining, microscopy, Zbinden toxicopathology case collection and peer review.

"Two areas are vital for an effective histopathology service — quality of production and data, and speed of throughput and response, and these are what our new team is able to deliver," said Ciriaco Maraschiello, Ph.D., director of drug discovery and translational medicines for Harlan Laboratories CRS.

"Thanks in part to our reputation throughout the contract research industry, Wendy has been able to build a team of the very best talent from both the CRO and pharmaceutical industries that will enable us to deliver high-quality pathology services to all of our clients."

About Harlan Contract Research Services
Harlan Contract Research Services (CRS), a division of Harlan Laboratories, Inc., is a privately held provider of general and specialty toxicology services to the global chemical, agrochemical and pharmaceutical industries. With laboratory locations in Germany, Spain, Switzerland and the UK, Harlan CRS' focus is on providing customers with services to optimize product development. For more information, please visit www.harlan.com/crs.

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.